Engraftment syndrome following hematopoietic stem cell transplantation

Bone Marrow Transplantation

Volumn 27, Issue 9, 2001, Pages 893-898

  Spitzer, T R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Engraftment syndrome; Stem cell transplantation

Indexed keywords

CORTICOSTEROID; CYTOKINE;

ALLOTRANSPLANTATION; AUTOTRANSPLANTATION; CELL POPULATION; CLINICAL FEATURE; CONTROLLED STUDY; EFFECTOR CELL; FEVER; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LUNG EDEMA; MORTALITY; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RASH; REVIEW; STEROID THERAPY;

CAPILLARY LEAK SYNDROME; CYTOKINES; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEUTROPHILS; SYNDROME;

EID: 0034988517     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703015     Document Type: Review

References (43)

1. Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation
2. Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation
3. An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose
4. Engraftment syndrome after autologous peripheral blood stem cell transplantation with high numbers of peripheral blood stem cells followed by granulocyte colony-stimulating factor administration
5. Marrow engraftment and clinical manifestations of capillary leak syndrome
6. Risk factors for capillary leakage syndrome after bone marrow transplantation
7. Increased frequency of autoaggression syndrome associated with autologous stem cell transplantation in breast cancer patients
8. Aseptic shock syndrome after bone marrow transplantation
9. Multiple organ dysfunction syndrome in bone marrow transplantation
10. Engraftment syndrome following non-myeloablative conditioning therapy and HLA-matched bone marrow transplantation for hematologic malignancy
11. Engraftment syndrome in breast cancer patients after BM/peripheral blood stem cell transplant is associated with poor long-term survival
12. Mismatched family donors for bone-marrow transplantation as treatment for acute leukemia
13. Mismatched family bone marrow transplantation
14. Mixed lymphohematopoietic chimerism is achievable following non-myeloablative therapy and HLA-mismatched donor marrow transplantation
15. Haploidentical donor bone marrow transplantation for advanced hematologic malignancy following non-myeloablative preparative therapy: Role of in vivo T cell depletion with anti-thymocyte globulin or anti-CD2 monoclonal therapy (MEDI-507)
16. The role of cytokines in graft-versus-host reactions and disease
17. Cytokine dysregulation and acute graft-versus-host disease
18. Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support
19. Levels of the terminal complement complex, C3a-desArg and C1-inhibitor in adult patients with capillary leak syndrome following bone marrow transplantation
20. Pathophysiologic mechanisms of acute graft-vs-host disease
21. Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome
22. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
23. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
24. International induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies
25. Increased serum levels of tumor necrosis factor precede major complications of bone marrow transplantation
26. Drug-induced pulmonary disease: Part 1: Cytotoxic drugs
27. Pulmonary hemorrhage as a cause of death in allogeneic bone marrow recipients with severe acute graft-versus-host disease
28. Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: Cryptic etiology and uncertain therapy
29. Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients
30. Production of tumor necrosis factor alpha and interferon gamma in interleukin-2-treated melanoma patients: Correlation with clinical toxicity
31. Fibrinolysis, thrombocytopenia, and coagulation abnormalities complicating high dose interleukin-2 immunotherapy
32. Regulation of transendothelial neutrophil migration by endogenous interleukin-8
33. Interleukin-8 induces neutrophil transendothelial migration
34. ICAM-1 expression on epidermal keratinocytes in cutaneous graft-versus-host disease
35. Graft-versus-host disease: New directions for a persistent problem
36. C1 esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation
37. Outcome of recipients of bone marrow transplants who require intensive-care unit support
38. Outcome of patients requiring medical ICU admission following bone marrow transplantation
39. Survival of adult bone marrow transplant patients receiving mechanical ventilation: A case for restricted use
40. Engraftment syndrome and survival after respiratory failure post-bone marrow transplantation
41. Successful management of adult respiratory distress syndrome (ARDS) after high-dose chemotherapy and peripheral blood progenitor cell rescue by non-invasive ventilatory support
42. Corticosteroids as adjunctive therapy for diffuse alveolar hemorrhage associated with bone marrow transplantation
43. High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients